3rd Annual Bioprocessing Summit Europe Virtual attracts more than 400 participants

Attendance, again, grows by more than 10% year-on-year

Bioprocessing Summit Europe Virtual 2020 at a glance

The 3rd Annual Bioprocessing Summit Europe was recently held virtually on 21-23 July and was attended by more than 400 bioprocessing scientists interested in the latest developments in Upstream and Downstream Processing, Cell & Gene Therapy, Analytic & Formulation, and much more.

The 2020 program offered 8 distinct conferences, and 10 Keynote presentations, focused on advances in all aspects of Cell Culture to Bioproduction, Cell Line to Protein Expression, Continuous Processing, Recovery and Purification, Cell Therapy CMC and Manufacturing, Gene Therapy CMC and Manufacturing, Analytical Characterisation and Formulation, as well as Stability and Aggregation

2020 Event Featured

  • 400+ Participants
  • 8 Conferences
  • 10 Keynote Presentations
  • Interactive Breakout Discussions
  • Dedicated Exhibit Hall Hours & Networking Functions


  • 40% of the attendees titled as a decision-maker from leading Pharma (20%), Biotech companies (64%) and, Academic learning institutions (12%).
  • Industry leaders representing 25 different countries
  • More than 250 unique organizations shared case studies, collaborated on best practices, and provided unique perspectives on poignant issues that the field currently faces.

The impressive audience came together for invaluable networking opportunities with more than

Please visit our website in the near future for our March 2021 dates, location and format



Continuous Processing for Vaccine Manufacturing: Challenges and Opportunities

Yan-Ping Yang, PhD
Head of Bioprocess Research & Development, North America, Sanofi Pasteur


Gene Therapy Manufacturing and Technical Development

Diane Blumenthal, PhD
Head, Technical Development, Spark Therapeutics


Gerald Gellermann, PhD

Gerald Gellermann, PhD
Senior Fellow, Analytical Development, Novartis

Nicolas P. Mermod, PhD

Nicolas P. Mermod, PhD
Professor & Director, Biology & Medicine, University of Lausanne

Massimo Morbidelli, PhD

Massimo Morbidelli, PhD
Professor, Chemical and Bioengineering, ETH Zurich

Florence Salmon, PhD

Christopher Bravery, PhD
Consultant, Advanced Biologicals Ltd
Consulting Regulatory Scientist


Stefan R. Schmidt, PhD
MBA, COO, Head, Operations, BioAtrium AG


Fethi Bensaid, PhD
Section Head, Formulation & Process Development, Sanofi Aventis


Sophia Hober, PhD,
Professor, School of Biotechnology, KTH Royal Institute of Technology

James Warren, PhD

James Warren, PhD

Vice President, Pharmaceutical Development, Ultragenyx

Premier Sponsors

Join The Community at Bioprocessing Summit Europe

View prospectus & attendee breakdown
View details

Hear industry updates straight from bioprocess innovators
Learn more